ArticleCell death & disease2026

PHKG2 confers resistance of ESCC to cisplatin and enhances CXCL8-dependent immunosuppression to exacerbate tumorigenesis.

Jiayan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.